Crossmark

Pancitopenia grave como reacción adversa al empleo de adalimumab biosimilar

Crossref DOI link: https://doi.org/10.1016/j.piel.2021.03.013

Published Print: 2022-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Díez-Madueño, Kevin

Matarranz del Amo, Mariano

Cebrián Méndez, Laura

Velázquez Tarjuelo, Diana

de la Cueva Dobao, Pablo
License Information

Text and Data Mining valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01
More Information

This article is maintained by: Elsevier

Article Title: Pancitopenia grave como reacción adversa al empleo de adalimumab biosimilar

Journal Title: Piel

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.piel.2021.03.013

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.